Rubicon Research IPO Allotment Status: Check Your Application, GMP, and Subscription Trends

Rubicon Research’s IPO has closed, and the numbers are out. The response was massive; the issue got subscribed to 103.65 times overall, with institutions going all in. The GMP also climbed steadily and settled at ₹127, hinting at a strong listing.

If you applied, here’s everything you need to know: how to check your allotment status, the final subscription numbers, what the GMP means, and when you’ll get your shares.

IPO Overview

• Allotment Date: October 14, 2025
• Listing Date: October 16, 2025 (Tentative)
• IPO Size: ₹1,377.5 crore (Fresh issue + Offer for Sale)
• Minimum Investment: ₹14,550
• Price Band: ₹461 to ₹485 per share

How to Check Rubicon Research IPO Allotment Status

There are two main ways to check your allotment status - through the official registrar’s website and through the stock exchanges (BSE/NSE). Rubicon Research’s IPO registrar is Link Intime India Pvt. Ltd.

Method 1: BSE India Website

1. Go to BSE IPO allotment page: https://www.bseindia.com/investors/appli_check.aspx
2. Select “Equity” in the issue type.
3. Choose “Rubicon Research Limited” from the company list.
4. Enter your Application Number or PAN.
5. Click “Search” to view results.

Method 2: Via Registrar (Link Intime)

1. Go to this link: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
2. In the drop-down menu, select “Rubicon Research Limited”.
3. Choose one of the following identification options:
   • PAN (Permanent Account Number)
   • Application Number (found in your IPO application form)
   • DP ID / Client ID (your demat account number)
4. Click “Search”.
   • If you are allotted shares, you’ll see the number of shares allotted.
   • If not allotted, it will say “No allotment” or “Not allotted”.

Subscription Trend for Rubicon Research IPO

Here’s how much each investor group applied:

What this means:

• Retail investors (like you and me) applied 34 times more than available shares, so only about 1 in 34 people will get the full allotment.
• Institutions (QIBs and NIIs) showed huge confidence, especially QIBs at 130x, this is a strong sign that big players believe in Rubicon’s long-term story.
• The overall 103.65x subscription means the IPO was one of the most sought-after in 2025, showing strong trust in the company’s US-focused pharma model.

Also Read: Rubicon Research IPO Explained: GMP, Strengths, Risks - Should You Invest?

Rubicon Research IPO GMP Update - What It Tells Us

GMP is an unofficial indicator of how much investors are willing to pay above the IPO price in the open market. It’s not guaranteed, but it gives a sense of early demand.

Source: chittorgarh.com

What This Means:

• The GMP rose every day, ending at ₹127.
• It means investors are ready to pay ₹612 on the listing day, even though the IPO price is ₹485.
• A rising GMP, especially on the last day, shows no profit booking - traders are still bullish, which increases the chance of a strong listing gain.
• But remember: GMP is not a guarantee. Market mood on listing day can change everything.

What Should You Expect?

Rubicon Research’s IPO has seen exceptional demand from both retail and institutional investors. The high QIB subscription suggests strong confidence in the company’s future, especially its growth in the US generic and specialty drug market.

If you applied, don’t expect full allotment - with 34x retail oversubscription, most people will get partial or no shares. But if you do get them, the early signs point to a healthy listing gain.

Still, remember: short-term gains are not everything. The real test is how the company performs over the next few years, its R&D strength, USFDA approvals, and ability to grow profits.

Disclaimer

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. The securities are quoted as an example and not as a recommendation. This is nowhere to be considered as advice, recommendation, or solicitation of an offer to buy or sell or subscribe for securities. INDStocks SIP / Mini Save is a SIP feature that enables Customer(s) to save a fixed amount on a daily basis to invest in Indian stocks. INDstocks Private Limited (formerly known as INDmoney Private Limited) 616, Level 6, Suncity Success Tower, Sector 65, Gurugram, 122005, SEBI Stock Broking Registration No: INZ000305337, Trading and Clearing Member of NSE (90267, M70042) and BSE, BSE StarMF (6779), SEBI Depository Participant Reg. No. IN-DP-690-2022, Depository Participant ID: CDSL 12095500, Research Analyst Registration No. INH000018948 BSE RA Enlistment No. 6428. Refer to https://indstocks.com/pricing?type=indian-stocks; https://www.indstocks.com/page/indian-stocks-sip-terms-and-condition for further details.